To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Description:QuantiChrom™ α-L-Fucosidase Assay Kit
- Size:100 assays
- Environmentally Preferable:
- Cat. No.:76237-104
Specifications
About this item
For quantitative determination of α-L-Fucosidase activity in biological samples (example: plasma, serum, tissue, cell lysate, and more.)
- High sensitivity and wide linear range, linear detection range (10 μl sample): 1 to 100 U/l
- Homogeneous and simple procedure
- simple add-mix-read procedure allows reliable quantitation of fucosidase activity within 20 minutes
- Robust and amenable to HTS
- Method:OD405 nm
- Samples: Plasma, serum, tissue, cell lysate, and more
All reagents are compatible with high-throughput liquid handling instruments. Can be readily automated to measure thousands of samples per day. α-L-Fucosidase (AFU) is an enzyme coded by the FUCA1 gene in humans and catalyzes the breakdown of L-Fucose. A genetic deficiency in this enzyme results in a neurovisceral storage disease, fucosidosis, which is characterized by the accumulation of fucose. Low serum activity of fucosidase has also been linked to ovarian caricinoma. Elevated fucosidase serum activity has been observed in patients with diabetes, hyperthyroidism, cirrhosis, and hepatitis. Increased activity has been associated with lung, breast, stomach, ovary, uterus, and liver carcinomas.
Non-radioactive, colorimetric AFU assay is based on the cleavage of 4-nitrophenol from the synthetic substrate. Nitrophenol becomes intensely colored after addition of the stop reagent. The increase in absorbance at 405 nm after addition of the stop reagent is directly proportional to the enzyme activity.